Cargando…
THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA
BACKGROUND: Hepatitis B Virus (HBV) co-infection is prevalent among HIV infected individuals because of shared routes and mechanisms of transmission. The multidimensional immunosuppression from HIV infection causes impaired spontaneous recovery from an acute HBV infection, predisposing to chronic in...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
African Traditional Herbal Medicine Supporters Initiative (ATHMSI)
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349760/ https://www.ncbi.nlm.nih.gov/pubmed/28331915 http://dx.doi.org/10.21010/ajid.v10i2.1 |
_version_ | 1782514532933959680 |
---|---|
author | Davidson, Uleanya Nwachinemere Chidiebele, Nwokoye Ikenna Josephine, Emodi Ifeoma Olakunle, Obidike Egbuna Nnaemeka, Ikefuna Anthony Chijioke, Eze Jude Kingsley, Ndu Ikenna |
author_facet | Davidson, Uleanya Nwachinemere Chidiebele, Nwokoye Ikenna Josephine, Emodi Ifeoma Olakunle, Obidike Egbuna Nnaemeka, Ikefuna Anthony Chijioke, Eze Jude Kingsley, Ndu Ikenna |
author_sort | Davidson, Uleanya Nwachinemere |
collection | PubMed |
description | BACKGROUND: Hepatitis B Virus (HBV) co-infection is prevalent among HIV infected individuals because of shared routes and mechanisms of transmission. The multidimensional immunosuppression from HIV infection causes impaired spontaneous recovery from an acute HBV infection, predisposing to chronic infection which is worsened by younger age at infection. Co-infection increases the risk of HBV replication, hepatotoxicity and liver related deaths from Highly Active Antiretroviral Therapy (HAART). The study was undertaken to highlight the burden of co-infection among HIV positive children in Enugu, determine the associated risk factors and compare the effect of co-infection between co-infected and non-co-infected children using liver enzyme and CD4 counts. MATERIALS AND METHODS: A cross sectional study was carried out among HIV positive children attending the Paediatric ARV clinic of the University of Nigeria Teaching Hospital, Ituku-Ozalla. A total of 140 HIV infected children aged 18 months to 15 years were recruited. An interviewer questionnaire was administered. Hepatitis B surface antigen (HBsAg) was determined using Determine test Kit. Baseline and recent CD4 counts/CD4% were retrieved from the patients’ folders. RESULTS: Fourteen (10%) were positive for HBsAg. The highest prevalence of HBsAg was observed among children aged 11- 15 years. The higher the socioeconomic class the less likely the HBsAg positivity. Seven (50%) of the co-infected children had elevated baseline ALT compared with 57 (45.2%) of non-co-infected children though the difference was not statistically significant (t = 0.6, P = 0.56). After the initiation of HAART, 10 (76.9%) of the co-infected and 18 (15.1%) of the non-co-infected children had elevated ALT. The baseline median CD4 count among children ≥ 6 years was 230 cells/mm(3) and 360 cells/mm(3) respectively among the co-infected and non- co-infected, (P = 0.67). However, in children ≤ 5 years, it was 25% and 15 % respectively (P = 0.06). CONCLUSION: HBV co-infection among HIV infected children is common in our environment, and co-infection is associated with impaired immunity and probably liver enzyme derangement. |
format | Online Article Text |
id | pubmed-5349760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | African Traditional Herbal Medicine Supporters Initiative (ATHMSI) |
record_format | MEDLINE/PubMed |
spelling | pubmed-53497602017-05-01 THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA Davidson, Uleanya Nwachinemere Chidiebele, Nwokoye Ikenna Josephine, Emodi Ifeoma Olakunle, Obidike Egbuna Nnaemeka, Ikefuna Anthony Chijioke, Eze Jude Kingsley, Ndu Ikenna Afr J Infect Dis Article BACKGROUND: Hepatitis B Virus (HBV) co-infection is prevalent among HIV infected individuals because of shared routes and mechanisms of transmission. The multidimensional immunosuppression from HIV infection causes impaired spontaneous recovery from an acute HBV infection, predisposing to chronic infection which is worsened by younger age at infection. Co-infection increases the risk of HBV replication, hepatotoxicity and liver related deaths from Highly Active Antiretroviral Therapy (HAART). The study was undertaken to highlight the burden of co-infection among HIV positive children in Enugu, determine the associated risk factors and compare the effect of co-infection between co-infected and non-co-infected children using liver enzyme and CD4 counts. MATERIALS AND METHODS: A cross sectional study was carried out among HIV positive children attending the Paediatric ARV clinic of the University of Nigeria Teaching Hospital, Ituku-Ozalla. A total of 140 HIV infected children aged 18 months to 15 years were recruited. An interviewer questionnaire was administered. Hepatitis B surface antigen (HBsAg) was determined using Determine test Kit. Baseline and recent CD4 counts/CD4% were retrieved from the patients’ folders. RESULTS: Fourteen (10%) were positive for HBsAg. The highest prevalence of HBsAg was observed among children aged 11- 15 years. The higher the socioeconomic class the less likely the HBsAg positivity. Seven (50%) of the co-infected children had elevated baseline ALT compared with 57 (45.2%) of non-co-infected children though the difference was not statistically significant (t = 0.6, P = 0.56). After the initiation of HAART, 10 (76.9%) of the co-infected and 18 (15.1%) of the non-co-infected children had elevated ALT. The baseline median CD4 count among children ≥ 6 years was 230 cells/mm(3) and 360 cells/mm(3) respectively among the co-infected and non- co-infected, (P = 0.67). However, in children ≤ 5 years, it was 25% and 15 % respectively (P = 0.06). CONCLUSION: HBV co-infection among HIV infected children is common in our environment, and co-infection is associated with impaired immunity and probably liver enzyme derangement. African Traditional Herbal Medicine Supporters Initiative (ATHMSI) 2016-05-01 /pmc/articles/PMC5349760/ /pubmed/28331915 http://dx.doi.org/10.21010/ajid.v10i2.1 Text en Copyright: © 2016 Afr. J. Infect. Diseases http://creativecommons.org/licenses/CC-BY/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License |
spellingShingle | Article Davidson, Uleanya Nwachinemere Chidiebele, Nwokoye Ikenna Josephine, Emodi Ifeoma Olakunle, Obidike Egbuna Nnaemeka, Ikefuna Anthony Chijioke, Eze Jude Kingsley, Ndu Ikenna THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA |
title | THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA |
title_full | THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA |
title_fullStr | THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA |
title_full_unstemmed | THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA |
title_short | THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA |
title_sort | prevalence liver function and immunologic status of children with hiv and hepatitis b virus coinfection in enugu, nigeria |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349760/ https://www.ncbi.nlm.nih.gov/pubmed/28331915 http://dx.doi.org/10.21010/ajid.v10i2.1 |
work_keys_str_mv | AT davidsonuleanyanwachinemere theprevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria AT chidiebelenwokoyeikenna theprevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria AT josephineemodiifeoma theprevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria AT olakunleobidikeegbuna theprevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria AT nnaemekaikefunaanthony theprevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria AT chijiokeezejude theprevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria AT kingsleynduikenna theprevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria AT davidsonuleanyanwachinemere prevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria AT chidiebelenwokoyeikenna prevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria AT josephineemodiifeoma prevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria AT olakunleobidikeegbuna prevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria AT nnaemekaikefunaanthony prevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria AT chijiokeezejude prevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria AT kingsleynduikenna prevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria |